✦ LIBER ✦

Presence of multiple genotype-specific antibodies in patients with persistent infection with hepatitis C virus (HCV) of a single genotype: evidence for transient or occult superinfection with HCV of different genotypes

✍ Scribed by Hidenori Toyoda; Yoshihide Fukuda; Tetsuo Hayakawa; Takashi Kumada; Satoshi Nakano; Junki Takamatsu; Hidehiko Saito

Book ID: 119396484
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 75 KB
Volume: 94
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(99)00354-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations in the NS5A gene of hepatitis

Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b

✍ Hofgärtner, Wolfgang T.; Polyak, Stephen J.; Sullivan, Daniel G.; Carithers, Rob 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB 👁 3 views

Previous studies from Japan have described an association between a conserved sequence within the hepatitis C virus (HCV) genome and resistance to interferon (IFN) therapy for patients infected with HCV genotype 1b [

Emergence of occult minority genotype 2b

Emergence of occult minority genotype 2b hepatitis C infection in an HIV-1-co-infected patient treated for genotype 5a HCV infection with 48 weeks of pegylated-interferon-α 2b and ribavirin

✍ A.J. Buckton; R. Kulasegaram; S.L. Ngui; M. Fisher; R. James; S. Rangarajan; C.G 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 362 KB

Peginterferon alfa-2b plus ribavirin for

Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3

✍ Stefan Zeuzem; Rolf Hultcrantz; Marc Bourliere; Tobias Goeser; Patrick Marcellin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Prevalence of wild-type in interferon se

Prevalence of wild-type in interferon sensitivity determining region (ISDR) of hepatitis C virus in HIV-1 positive patients infected with HCV genotype 3A non responders to anti-HCV treatment

✍ Sabrina Bagaglio; Raffaele Bruno; Anna De Bona; Caterina Uberti-Foppa; Renato Fi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB

A randomized, double-blind, multiple-dos

A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4

✍ Vince, Bradley; Hill, John M.; Lawitz, Eric J.; O’Riordan, William; Webster, Lyn 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 857 KB

Effect of antiviral treatment on evoluti

Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: Evidence for a role of HCV genotype 3 in steatosis

✍ L. Castera; C. Hezode; F. Roudot-Thoraval; I. Lonjon; E.S. Zafrani; J.M. Pawlots 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB